New patent expiration for Baxter Hlthcare drug NEXTERONE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for NEXTERONE
Annual Drug Patent Expirations for NEXTERONE

Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.

Drug patent litigation for NEXTERONE.

This drug has forty-seven patent family members in twenty countries.

The generic ingredient in NEXTERONE is amiodarone hydrochloride. Two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top